Researcher | Research Overview
Dr. Boulias is interested in the emerging field of epitrancriptomics, which encompasses the biology of RNA modifications and their associated factors. He is focused on determining the genetic and molecular basis of the control of gene expression by specific mRNA modifications. In particular, he investigates the functions of N6-methyladenosine in RNA biology in response to physiological and environmental stimuli using a variety of biochemical and cell biology tools in cell lines and murine experimental models. His ultimate goal is to identify new players and novel mechanisms of RNA metabolism that can be utilized as targets of therapeutic action for the treatment of related diseases.
Researcher | Research Background
Dr. Boulias received his PhD degree from University of Crete, Greece. He completed his postdoctoral training at MIT and then moved to BCH as Senior Research Associate. In 2018 he was appointed as Instructor in Pediatrics at BCH and HMS.